Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2361412 | 0.92 | DNM1 (0.40) | PLA2G1BPLA2G2AOPRM1ALDH1A1DNM1 | |
| SCHEMBL8679255 | 0.90 | DNM1 (0.44) | PLA2G1BPLA2G2AOPRM1ALDH1A1DNM1 | |
| SCHEMBL10810975 | 0.90 | DNM1 (0.44) | PLA2G1BPLA2G2AOPRM1ALDH1A1DNM1 | |
| SCHEMBL2933963 | 0.90 | DNM1 (0.44) | PLA2G1BPLA2G2AOPRM1ALDH1A1DNM1 | |
| SCHEMBL258808 | 0.83 | FDPS (0.37) | CA12CA1 | |
| SCHEMBL29767944 | 0.83 | DNM1 (0.46) | PLA2G1BPLA2G2AALDH1A1DNM1TSHR | |
| SCHEMBL3460398 | 0.82 | PLA2G1B (0.39) | PLA2G1BPLA2G2AOPRM1MMP1MMP2 | |
| SCHEMBL20774234 | 0.82 | PLA2G1B (0.39) | PLA2G1BPLA2G2AOPRM1MMP1MMP2 | |
| SCHEMBL2839059 | 0.80 | ALDH1A1 (0.39) | ALDH1A1TDP1DNM1TSHR | |
| SCHEMBL3650242 | 0.80 | LMNA (0.38) | PLA2G1BPLA2G2AOPRM1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1042 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11883790-B2 | Hollow particles, method for producing same, and usage of same | SEKISUI KASEI CO., LTD. (JP) | 2024-01-30 | — | — | US | claimed |
| CN-112512498-B | Hair cosmetic | 花王株式会社 | 2023-09-12 | — | — | CN | claimed |
| CN-111902206-B | Hollow particles, method for producing same, and use thereof | 积水化成品工业株式会社 | 2023-03-24 | — | — | CN | claimed |
| US-20220363976-A1 | ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES | CHAMPIONX LLC | 2022-11-17 | — | — | US | claimed |
| US-11414588-B2 | Alkyl lactone-derived hydroxyamides and alkyl lactone-derived hydroxyesters for the control of natural gas hydrates | CHAMPIONX USA INC. (US) | 2022-08-16 | — | — | US | claimed |
| EP-3891260-A1 | HYDROGEN SULPHIDE AND MERCAPTANS SCAVENGING COMPOSITIONS | Total Marketing Services (FR) | 2021-10-13 | — | — | EP | claimed |
| EP-3807382-A1 | CARBOXY ALKYL-ESTER ANTI-AGGLOMERANTS FOR THE CONTROL OF NATURAL GAS HYDRATES | ChampionX USA Inc. (US) | 2021-04-21 | — | — | EP | claimed |
| EP-3766571-A1 | HOLLOW PARTICLES, METHOD FOR PRODUCING SAME, AND USAGE OF SAME | SEKISUI KASEI CO., LTD. (JP) | 2021-01-20 | — | — | EP | claimed |
| US-20210001300-A1 | HOLLOW PARTICLES, METHOD FOR PRODUCING SAME, AND USAGE OF SAME | SEKISUI KASEI CO., LTD. (JP) | 2021-01-07 | — | — | US | claimed |
| CN-111902206-A | Hollow particles, method for producing same, and use thereof | 积水化成品工业株式会社 | 2020-11-06 | — | — | CN | claimed |
| US-6723836-B1 | REACTING POLYOL WITH A PRIMARY AMINE TO REDUCE THE ALDEHYDE ODOR | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2004-04-20 | — | — | US | claimed |
| US-6713146-B2 | SINGLY RECORDABLE COMPACT DISC (CD-R) | BAYER AKTIENGESELLSCHAFT (DE) | 2004-03-30 | — | — | US | claimed |
| US-20020127366-A1 | Optical data stores containing a Co-phthalocyanine complex in the information layer recordable using light | LANXESS DEUTSCHLAND GMBH (DE) | 2002-09-12 | — | — | US | claimed |
| EP-0748855-B1 | Heatset intaglio printing ink | SUN CHEMICAL CORP (US) | 1999-07-07 | — | — | EP | claimed |
| US-5723514-A | PARTIALLY CONJUGATED FATTY ACID ESTER OF EPOXY RESIN, (DIALKYLAMINO)ALKYLAMINE | SUN CHEMICAL CORPORATION (US) | 1998-03-03 | — | — | US | claimed |
| EP-0748855-A1 | Heatset intaglio printing ink | SUN CHEMICAL CORPORATION (US) | 1996-12-18 | — | — | EP | claimed |
| US-5281264-A | Salt of disazo acid dye containing pyrrazole ring and basic dye, inks | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 1994-01-25 | — | — | US | claimed |
| EP-0512527-A1 | Modified cellulose polymer, blood processor and process for producing same | TEIJIN LIMITED (JP) | 1992-11-11 | — | — | EP | claimed |
| US-4138377-A | FOR CATHODE ELECTRODEPOSITION | NIPPON OIL COMPANY, LTD. (JP) | 1979-02-06 | — | — | US | claimed |
| US-4072536-A | PAINTS | NIPPON OIL COMPANY, LTD. (JA) | 1978-02-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11414588-B2 | Alkyl lactone-derived hydroxyamides and alkyl lactone-derived hydroxyesters for the control of natural gas hydrates | HDHD5, HACL2, ADH5 | PLA2G1B 1444/4885PLA2G2A 829/4885OPRM1 4127/4885 |
| US-20220363976-A1 | ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES | HDHD5, HACL2, ADH5 | PLA2G1B 1444/4885PLA2G2A 829/4885OPRM1 4127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.